An abstract and poster co-authored by Quantify’s Hanna Fues Wahl, Rosa Lauppe, and Mathias Lilja will be presented at the ESMO – European Society for Medical Oncology Congress 2021, taking place 16-21 September. For this abstract, called “Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study”, the Quantify team has provided RWE results on Swedish data.
Key findings on Swedish palbociclib dose patterns include a slightly more common occurrence of dose reductions in clinical practice, but with a falling trend approaching clinical trial findings over time.
Access the abstract here:
Read more about the conference programme via the link below: